N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
- CAS No.
- 83461-56-7
- Chemical Name:
- N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
- Synonyms
- MIFAMURTIDE;MTP-PE;CGP 19835;MLV 19835;MTP-cephalin;L-MTP-PE. MTP-PE;CGP 19835A Lipid;Mifamurtide (CGP-19835);muramyl tripeptide phosphatidylethanolamine;muramyl tripeptide phosphatidylethanolamine liposome
- CBNumber:
- CB11249151
- Molecular Formula:
- C59H109N6O19P
- Molecular Weight:
- 1237.52
- MDL Number:
- MFCD09954133
- MOL File:
- 83461-56-7.mol
| Density | 1.152 |
|---|---|
| storage temp. | -20°C |
| solubility | water: soluble2mg/mL, clear (warmed) |
| form | powder |
| pka | 1.39±0.50(Predicted) |
| color | white to beige |
| InChIKey | ZVLWUMPAHCEZAW-HYGHKABSNA-N |
| CAS DataBase Reference | 83461-56-7 |
| NCI Dictionary of Cancer Terms | mifamurtide; muramyl tripeptide phosphatidylethanolamine |
| FDA UNII | EQD2NNX741 |
| NCI Drug Dictionary | mifamurtide |
| ATC code | L03AX15 |
N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine price More Price(7)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| TRC | M343940 | Mifamurtide | 83461-56-7 | 25mg | $13390 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FM36618 | Mifamurtide | 83461-56-7 | 0.5mg | $800 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FM36618 | Mifamurtide | 83461-56-7 | 1mg | $1000 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FM36618 | Mifamurtide | 83461-56-7 | 2mg | $1200 | 2021-12-16 | Buy |
| Biosynth Carbosynth | FM36618 | Mifamurtide | 83461-56-7 | 5mg | $1500 | 2021-12-16 | Buy |
N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine Chemical Properties,Uses,Production
Uses
Osteosarcoma.
Uses
Mifamurtide may be used in immunological and cancer-related cell signaling studies.
Biochem/physiol Actions
Mifamurtide is an immunomodulator and regulates the activation of monocytes and macrophages. Mifamurtide upregulates the secretion of pro-inflammatory cytokines such as TNF-α, IL-1, IL-8, nitric oxide and prostaglandins E2 and D2. It has anti-tumor effects in children and young adults with high-grade osteosarcoma.
Mechanism of action
Being a phospholipid, mifamurtide accumulates in the lipid bilayer of the liposomes upon infusion. After application of the liposomal infusion, the drug is cleared from the plasma within minutes. However, it is concentrated in lung, liver, spleen, nasopharynx and thyroid, and the terminal half-life is 18 hours, which is longer than the natural substance.
Clinical Use
Mifamurtide is an anticancer agent for the treatment of osteosarcoma, the most common primary malignancy of bone tissue mainly affecting children and adolescents. The drug was invented by Ciba-Geigy (now Novartis) in the early 1980s and the agent was subsequently licensed to Jenner Biotherapies in the 1990s. IDM Pharma bought the rights to the drug from Jenner in April 2003.In March 2009, mifamurtide was approved in the 27 European Union member states plus Iceland, Liechtenstein and Norway via a centralized marketing authorization. After the approval, IDM Pharma was acquired by Takeda, which began launching mifamurtide, as Mepact ®, in February 2010. Mifamurtide, a fully synthetic lipophilic derivative of muramyl dipeptide (MDP), is muramyl tripeptide phosphatidylethanolamine (MTP-PE), which is formulated as a liposomal infusion.
Synthesis
Two synthetic routes have been reported, and the scheme describes the more process-amenable route. Commercially available 1,2-dipalmitoyl-snglycero- 3-phosphoethanolamine (110) was coupled with N-Boc-L-alanine (111) by means of Nhydroxysuccinimide (112), DCC in DMF to give amide 113, which was followed by hydrogenolysis of the CBZ group to give the corresponding L-alanyl-phosphoric acid 114. Next, commercially available N-acetylmuramoyl-L-alanyl-D-isoglutamine (115) was subjected to hydroxybenzotriazole (HOBT) and DIC in DMF to provide the corresponding succinimide ester 116 which was condensed with compound 114 to provide mifamurtide (IX). No yields were provided for these transformations.
Drug interactions
Potentially hazardous interactions with other drugs
Analgesics: avoid with high dose NSAIDs.
Ciclosporin: avoid concomitant use.
Corticosteroids: avoid concomitant use.
Tacrolimus: avoid concomitant use.
Metabolism
The cells of the reticuloendothelial system clear mifamurtide liposomes by phagocytosis.
N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Henan Bao Enluo International TradeCo.，LTD | +86-17331933971 +86-17331933971 | deasea125996@gmail.com | China | 2503 | 58 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21695 | 55 |
| career henan chemical co | +86-0371-86658258 | sales@coreychem.com | China | 29914 | 58 |
| Hubei Jusheng Technology Co.,Ltd. | 18871490254 | linda@hubeijusheng.com | CHINA | 28180 | 58 |
| Chongqing Chemdad Co., Ltd | +86-023-61398051 +8613650506873 | sales@chemdad.com | China | 39916 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354 +1-00000000000 | marketing@targetmol.com | United States | 19892 | 58 |
| Dideu Industries Group Limited | +86-29-89586680 +86-15129568250 | 1026@dideu.com | China | 29322 | 58 |
| BOC Sciences | +16314854226 | inquiry@bocsci.com | United States | 19743 | 58 |
| Hebei Duling International Trade Co. LTD | +8618032673083 | sales05@hbduling.cn | China | 15746 | 58 |
| Shanghai Acmec Biochemical Technology Co., Ltd. | +undefined18621343501 | product@acmec-e.com | China | 33349 | 58 |
View Lastest Price from N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2023-05-27 | N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
83461-56-7
|
US $45.00 / kg | 1kg | 99% | 20tons | Henan Bao Enluo International TradeCo.，LTD | |
 |
2023-05-27 | mifamurtide
83461-56-7
|
US $45.00 / kg | 1kg | 99% | 20tons | Henan Bao Enluo International TradeCo.，LTD | |
 |
2019-08-08 | N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
83461-56-7
|
US $1.00-2.00 / KG | 1KG | 98% | 1kg,10kg,100kg | Career Henan Chemical Co |
-
- N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
83461-56-7
- US $45.00 / kg
- 99%
- Henan Bao Enluo International TradeCo.，LTD
-
- mifamurtide
83461-56-7
- US $45.00 / kg
- 99%
- Henan Bao Enluo International TradeCo.，LTD
-
- N-Acetylmuramyl-alanyl-isoglutaminyl-alanyl-sn-glycero-3-phosphoethano lamine
83461-56-7
- US $1.00-2.00 / KG
- 98%
- Career Henan Chemical Co